Abstract
To assess the effects of tDCS on ADL and motor function in people with stroke. We searched the Cochrane Stroke Group Trials Register (January 2019), the CENTRAL (Cochrane Central Register of Controlled Trials; The Cochrane Library; 2019, Issue 1), MEDLINE (1948 to January 2019), Excerpta Medica Database (EMBASE, 1980 to January 2019), Cumulative Index to Nursing and Allied Health Literature (CINAHL, 1982 to January 2019), Allied and Complementary Database (AMED, 1985 to January 2019), Science Citation Index (1899 to January 2019), and 4 additional databases.1 We included all randomized trials in people with stroke which investigated the effects of tDCS versus any other comparator in adults with stroke. The primary outcome was ADL performance at study end and at follow-up; secondary outcomes were function, muscle strength, cognitive abilities, dropouts, and adverse events. Two review authors independently assessed risk of bias of included trials and extracted data.
Original language | English |
---|---|
Journal | Stroke |
Volume | 52 |
Issue number | 7 |
Pages (from-to) | E358-E359 |
ISSN | 0039-2499 |
DOIs | |
Publication status | Published - 01.07.2021 |
Research Areas and Centers
- Health Sciences
DFG Research Classification Scheme
- 206-07 Clinical Neurology Neurosurgery and Neuroradiology
- 206-08 Cognitive and Systemic Human Neuroscience